Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

Clinical trial NCT01266213 · UNKNOWN

Trial details

NCT number: NCT01266213
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Estrogen Receptor Positive Tumor Breast Cancer Nos Premenopausal

Start date: 2010-12-01
Primary completion: 2018-06-01
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.